Skip to content
Tablet Allopathic

Azilpres Plus 40 mg+12.5 mg tablet

Generic: Azilsartan Medoxomil + Chlorthalidone

Company: Incepta Pharmaceuticals Ltd.. Prices are as listed on BestinMeds; your pharmacy price may differ.

Strength40 mg+12.5 mg
PackNot listed yet

Reviewed by: not listed yet. Source: not listed yet.

Last updated March 5, 2025.

Compare

Same generic, same strength

Sorted by price per tablet. Ask your pharmacist before you switch brands.

Azilsartan Medoxomil + Chlorthalidone 40 mg+12.5 mg tablets

Prices as listed on BestinMeds.

2 brands listed

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250
Medicine guide

About this medicine

What this medicine is for, how to take it, and what to watch for.

Read the full Azilsartan Medoxomil + Chlorthalidone guide

Indications

Stroke For the treatment of hypertension, to lower blood pressure: In patients not adequately controlled with ARB monotherapy As initial therapy in patients likely to need multiple drugs to help To achieve blood pressure goals and to reduce the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.

Dosage and administration

The recommended starting dose is 40/12.5 mg taken orally once daily. Most of the antihypertensive effect is apparent within 1 to 2 weeks. This combination may be used to provide additional blood pressure lowering for patients not adequately controlled on ARB or diuretic monotherapy treatment. Patients not controlled with azilsartan medoxomil 80 mg may have an additional systolic/diastolic clinic blood pressure reduction of 13/6 mm Hg when switched to this combination 40/12.5 mg. This combination may be used as initial therapy if a patient is likely to need multiple drugs to achieve blood pressure goals. Patients titrated to the individual components (azilsartan medoxomil and chlorthalidone) may instead receive the corresponding dose of This combination.

Side effects

The following potential adverse reactions are- Fetal toxicity Hypotension in Volume- or Salt-Depleted Patients Impaired Renal Function Hypokalemia Hyperuricemia

Precautions and warnings

In patients with an activated renin-angiotensin-aldosterone system (RAAS), such as volume- and/or salt-depleted patients, this combination can cause excessive hypotension. Correct volume or salt depletion prior to administration of azilsartan and chlorthalidone. In patients with renal artery stenosis, This combination may cause renal failure. Monitor renal function in patients with renal impairment. Consider discontinuing this combination with progressive renal impairment. Heart rhythm problems (e.g., bradycardia, QT prolongation, ventricular tachycardia), liver problems, certain uncorrected mineral imbalances (low potassium/magnesium levels), severe kidney problems.

Pregnancy and lactation

Pregnancy Category D. Use of drugs that affect the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death.

Clinical details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250